Circulating endothelin in acute ischaemic syndromes.

S G Ray, J J McMurray, J J Morton, H J Dargie

Department of Cardiology, Western Infirmary, Glasgow, UK.

BACKGROUND--Endothelin is an extremely potent vasoconstrictor that may have a role in the pathogenesis of acute myocardial ischaemia. Atrial natriuretic factor is an endogenous antagonist of endothelin. To find the pattern and possible importance of circulating endothelin in ischaemic heart disease, concentrations in normal controls and those in patients with stable and unstable angina, acute myocardial infarction, and chronic cardiac failure were compared. The relation between circulating concentrations of endothelin and atrial natriuretic factor in the aftermath of myocardial infarction was also examined. METHODS--Eighteen patients with acute myocardial infarction, 10 with unstable angina, 10 with stable angina, 12 with chronic cardiac failure, and 10 normal controls were studied. Endothelin concentration was measured in venous plasma by radioimmunoassay. In patients with acute myocardial infarction simultaneous concentrations of endothelin and atrial natriuretic factor were measured on admission and at one, four, and 24 hours. RESULTS--Mean concentrations (SEM) of endothelin were 5.72 (0.19) fmol/ml in controls, 6.56 (0.48) fmol/ml in stable angina, 6.41 (0.48) fmol/ml in unstable angina, and 13.83 (0.95) fmol/ml in chronic cardiac failure. In acute myocardial infarction concentrations were 8.81 (0.69) fmol/ml on admission, 11.85 (1.02) fmol/ml at one hour, 11.88 (1.10) fmol/ml at four hours, and 7.30 (0.49) fmol/ml at 24 hours. Concentrations of atrial natriuretic factor at the same times were 68.1 (13.1) pg/ml, 8.4 (1.5) pg/ml, 24.4 (4.1) pg/ml, and 42.0 (6.9) pg/ml. CONCLUSIONS--Plasma endothelin is raised in chronic heart failure and in the aftermath of acute myocardial infarction but not in stable or unstable angina. After myocardial infarction endothelin concentrations are raised whereas concentrations of atrial natriuretic factor are relatively low. The role of endothelin in the pathogenesis of acute myocardial infarction and its interactions with other humoral factors require further investigation.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• O'Connor, C. M., Gattis, W. A., Adams, K. F. Jr, Hasselblad, V., Chandler, B., Frey, A., Kobrin, I., Rainisio, M., Shah, M. R., Teerlink, J., Gheorghiade, M., RITZ-4 Investigators, (2003). Tezosentan in patients with acuteheart failure and acute coronary syndromes: Results of the randomized intravenous tezosentan study (ritz-4). J Am Coll Cardiol 41: 1452-1457 [Abstract] [Full Text]  
• Lockowandt, U., Bjessmo, S., Ivert, T., Franco-Cereceda, A. (2002). Plasma levels and vascular effects of endothelin and big endothelin in patients with stable and unstable angina pectoris undergoing coronary bypass grafting. Eur. J. Cardiothorac. Surg. 21: 218-223 [Abstract] [Full Text]  
• Alioglu, Z., Orem, A., Bulbul, I., Boz, C., Ozmenoglu, M., Vanizor, B. (2002). Evaluation of Plasma Endothelin-1 Levels in Patients with Cerebral Infarction. ANGIOLOGY 53: 77-82 [Abstract]  
• Zouridakis, E.G., Schwartzman, R., Garcia-Moll, X., Cox, I.D., Fredericks, S., Holt, D.W., Kaski, J.C. (2001). Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 22: 1578-1584 [Abstract]  
• Spieker, L. E., Noll, G., Ruschitzka, F. T., Luscher, T. F. (2001). Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?. J Am Coll Cardiol 37: 1493-1505 [Abstract] [Full Text]  
• Desideri, G., Gaspardone, A., Gentile, M., Santucci, A., Gioffre, P. A., Ferri, C. (2000). Endothelial Activation in Patients With Cardiac Syndrome X. Circulation 102: 2359-2364 [Abstract] [Full Text]  
• Battistelli, S., Billi, M., Manasse, G., Vittoria, A., Roviello, F., Forconi, S. (1999). Behavior of Circulating Endothelin-1 in a Group of Patients with Acute Myocardial Infarction. ANGIOLOGY 50: 629-638 [Abstract]  
• Tiret, L., Poirier, O., Hallet, V., McDonagh, T. A., Morrison, C., McMurray, J. J. V., Dargie, H. J., Arveiler, D., Ruidavets, J.-B., Luc, G., Evans, A., Cambien, F. (1999). The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People. Hypertension 33: 1169-1174 [Abstract] [Full Text]  
• Anwaar, I., Gottsater, A., Lindgarde, F., Mattiasson, I. (1999). Increasing Plasma Neopterin and Persistent Plasma Endothelin During Follow-up After Acute Cerebral Ischemia. ANGIOLOGY 50: 1-8 [Abstract]  
• Zhang, Y., Oliver, J. R., Horowitz, J. D. (1998). Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Cardiovasc Res 39: 665-673 [Abstract] [Full Text]  
• Montalescot, G., Philippe, F., Ankri, A., Vicaut, E., Bearez, E., Poulard, J. E., Carrie, D., Flammang, D., Dutoit, A., Carayon, A., Jardel, C., Chevrot, M., Bastard, J. P., Bigonzi, F., Thomas, D. (1998). Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease : Beneficial Effects of Enoxaparin. Circulation 98: 294-299 [Abstract] [Full Text]  
• Fraccarollo, D., Hu, K., Galuppo, P., Gaudron, P., Ertl, G. (1997). Chronic Endothelin Receptor Blockade Attenuates Progressive Ventricular Dilation and Improves Cardiac Function in Rats With Myocardial Infarction : Possible Involvement of Myocardial Endothelin System in Ventricular Remodeling. Circulation 96: 3963-3973 [Abstract] [Full Text]  
• Mathew, V., Lerman, A. (1997). Clinical Implications of a Sandwich Enzyme Immunoassay for Big Endothelin-1. Clin. Chem. 43: 9-10 [Full Text]  
• Seccombe, J. F., Schaff, H. V. (1995). Coronary Artery Endothelial Function After Myocardial Ischemia and Reperfusion. Ann. Thorac. Surg. 60: 778-788 [Abstract] [Full Text]